Driving reinvestment in R&D for antibiotics and advocating their responsible use
Posted on
by
admin in
| NAME |
SURNAME |
ORGANISATION |
WORK STREAM |
| Stephen |
Harbarth |
University of Geneva |
Coordination of DRIVE-AB and WP3A leader |
| Inge |
Gyssens |
University Medical Centre, Nijmegen |
WP1A leader |
| Marlies |
Hulscher |
Radboud University Medical Centre, Nijmegen |
WP1A leader |
| Jeroen |
Schouten |
Radboud University Medical Centre, Nijmegen |
Partner in WP1A |
| Herman |
Goossens |
University of Antwerp |
Partner in WP1A |
| Niels |
Adriaenssens |
University of Antwerp |
Partner in WP1A |
| Benedikt |
Huttner |
University of Geneva |
Partner in WP1A |
| Céline |
Pulcini |
Nice University Hospital |
Partner in WP1A |
| Vera |
Vlahović-Palčevski |
Univerisity Hospital Rijeka, Croatia |
Partner in WP1A |
| Nicholas |
Brown |
British Society for Antimicrobial Chemotherapy |
Partner in WP1A and WP3B |
| Laura |
Piddock |
British Society for Antimicrobial Chemotherapy |
Partner in WP1A and WP3B |
| Tracey |
Guise |
British Society for Antimicrobial Chemotherapy |
Partner in WP1A and WP3B |
| Yehuda |
Carmeli |
Tel Aviv Sourasky Medical Center |
WP1B Leader |
| Evelina |
Tacconelli |
University of Tüebingen |
Partner in WP1B |
| Ramanan |
Laxminarayan |
London School of Tropical Medicine and Hygiene |
WP1C Leader |
| Timo |
Goeschl |
Heidelberg University |
Partner in WP1C |
| Justus |
Wesseler |
Technical University Munich |
Partner in WP1C |
| John-Arne |
Røttingen |
Norwegian Institute of Public Health |
Co-leader of WP2 |
| Otto |
Cars |
Uppsala University |
Co-leader of WP2 |
| Anna |
Zorzet |
Uppsall |
Partner in WP2 |
| Rifat |
Atun |
Imperial College London |
Partner in WP2 |
| Francesco |
Ciabuschi |
University of Uppsala |
Partner in WP2 |
| Enrico |
Baraldi |
University of Uppsala |
Partner in WP2 |
| Steve |
McKeever |
University of Uppsala |
Partner in WP2 |
| Elias |
Mossialos |
London School of Economics |
Partner in WP2 |
| Chantal |
Morel |
London School of Economics and University of Geneva |
Partner in WP2 |
| Suzanne |
Edwards |
University of Geneva |
Partner in WP2 |
| Christine |
Årdal |
Norwegian Institute of Public Health |
Partner in WP2 |
| Steven |
Hoffman |
Norwegian Institute of Public Health |
Partner in WP2 |
| Dimitrios |
Gouglas |
Norwegian Institute of Public Health |
Partner in WP2 |
| Ursula |
Theuretzbacher |
CEFAIA |
WP3B Leader |
| David |
Heymann |
Chatham House |
Partner in WP3B |
| Charles |
Clift |
Chatham House |
Partner in WP3B |
| Brigitte |
Nolet |
Roche, Head of Global Public Policy |
Co-leader of WP3B |
| Ka |
Lumb |
Roche, Head of Global Pricing and Market Access, Immunology, Infectious Diseases and Ophthalmology |
Participant in WP1C and WP2 |
